Clinical Trials Logo

Filter by:
NCT ID: NCT05188248 Completed - Depression Clinical Trials

A Pilot Study of the Immediate Effects of DLPFC tDCS on Attention Bias in Depression

Start date: December 15, 2021
Phase: N/A
Study type: Interventional

Depression and other psychiatric conditions are marked by exaggerated, preferential processing (or attention bias) of negative information relative to neutral or positive information. This depression-related attention bias can be measured using the Dot Probe task and Visual Search, that allow assessment of the degree to which one shows bias toward negative information in the presence of neutral or positive information. A clinically effective treatment for depression is noninvasive brain stimulation with transcranial direct current stimulation (tDCS), targeting the dorsolateral prefrontal cortex (DLPFC), delivered in repeated sessions across a period of time. The study will test the effect of a single session of DLPFC tDCS on attention bias in patients with mild to moderate depression.

NCT ID: NCT05188040 Completed - Clinical trials for Distal Radius Fracture

Effectiveness of Virtual Reality in Hand Therapy

Start date: May 16, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine if the use of Virtual Reality as an intervention for patients following specific hand injuries will positively affect patients with decreased hand function and reduce pain and improve outcomes. Participants will be recruited from 3 different clinics in central Kentucky.

NCT ID: NCT05187910 Completed - Clinical trials for Cognitive Impairment

Correlation Between Montreal Cognitive Assessment and Voice Therapy Outcomes in the Aging Treatment- Seeking Population

MoCA
Start date: March 1, 2021
Phase: N/A
Study type: Interventional

This study will investigate if the performance on the Montreal Cognitive Assessment (MoCA) is associated or predictive of the outcomes in voice, swallowing or upper airway therapy in the older laryngology treatment seeking patients. The relationship between the scores of MoCA and parameters in therapy will be analyzed. The outcomes of this study could potentially impact how investigators determine candidacy for therapy and develop patient treatment plans to meet their needs. This is a collaborative study with Emory Voice Center and the NYU Voice Center.

NCT ID: NCT05187364 Completed - Clinical trials for Alcohol Use Disorder

BioWare for AUD and PTSD

Start date: May 5, 2022
Phase: N/A
Study type: Interventional

This study examines the ability of an innovative telehealth technology system to enhance Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure (COPE) talk-therapy for individuals with posttraumatic stress disorder (PTSD) and alcohol use disorder.

NCT ID: NCT05187169 Completed - Food Effect Clinical Trials

Food Effect of VS-6766 in Healthy Adult Subjects

Start date: December 16, 2021
Phase: Phase 1
Study type: Interventional

An Open-Label, 2-Way, 2-Period Crossover Study of Orally Administered VS-6766 in Healthy Adult Subjects to Determine the Effect of Food on the Pharmacokinetics of VS-6766

NCT ID: NCT05187117 Completed - Depression Clinical Trials

CAPABLE Family Pilot - Adapting CAPABLE for Older Adults With Mild Cognitive Impairment (MCI)/Early Stage Dementia and Their Care Partners

Start date: March 9, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to test the adapted protocol, CAPABLE Family which builds upon the evidenced based CAPABLE program to address older adults with co-occurring physical disability and mild cognitive impairment or early stage dementia and the older adults' caregivers. It will consist of two phases - an open label pilot and waitlist control trial.

NCT ID: NCT05187078 Completed - IUD Clinical Trials

Allis Clamp Versus Single-tooth Tenaculum

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

This study aims to determine whether an Allis clamp is an effective clamp for cervical stabilization compared to a single-tooth tenaculum.

NCT ID: NCT05186831 Completed - Hypertension Clinical Trials

Patient-Portal vs Text-based Hypertension Monitoring Among Black Medicaid/Medicare Patients

Start date: October 19, 2020
Phase: N/A
Study type: Interventional

The coronavirus disease 2019 (COVID-19) pandemic has uprooted conventional health care delivery for routine ambulatory care, requiring health systems to rapidly adopt telemedicine capabilities. The digital divide, has been well documented with lower rates of technology and broadband adoption among racial/ethnic minorities. Additionally, Black patients suffer a disproportionate burden of hypertension and cardiovascular disease. This study will implement a text-based home hypertension monitoring program among Black Medicaid patients with hypertension and cardiovascular disease (CVD) and compare its uptake to the currently available blood pressure monitoring program using the patient portal that is integrated into the electronic health record (EHR).

NCT ID: NCT05186818 Completed - Clinical trials for Obstructive Hypertrophic Cardiomyopathy (oHCM)

Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM (SEQUOIA-HCM)

SEQUOIA-HCM
Start date: February 1, 2022
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of aficamten (CK-3773274) in adults with symptomatic hypertrophic cardiomyopathy and left ventricular outflow tract obstruction

NCT ID: NCT05186805 Completed - Atopic Dermatitis Clinical Trials

Maximal Use Study of Tapinarof Cream, 1% in Pediatric Subjects With Extensive Atopic Dermatitis

Start date: November 15, 2021
Phase: Phase 2
Study type: Interventional

This is an open-label, multicenter study to evaluate the systemic exposure and safety of topical tapinarof cream, 1% under conditions of maximal use in pediatric subjects with atopic dermatitis